| 1 |
30985942 | Application of a physiologically based pharmacokinetic model for the prediction of mirabegron plasma concentrations in a population with severe renal impairment. | 2019 May |
1 |
| 2 |
28520375 | Aripiprazole Therapy and CYP2D6 Genotype | 2012 |
1 |
| 3 |
21142269 | Effect of inhibition of cytochrome P450 enzymes 2D6 and 3A4 on the pharmacokinetics of intravenous oxycodone: a randomized, three-phase, crossover, placebo-controlled study. | 2011 |
1 |
| 4 |
20642550 | Exposure to oral oxycodone is increased by concomitant inhibition of CYP2D6 and 3A4 pathways, but not by inhibition of CYP2D6 alone. | 2010 Jul |
2 |
| 5 |
16633141 | Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects. | 2006 Apr |
3 |
| 6 |
16321618 | Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients. | 2005 Nov |
3 |